Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

About SoftCure

Developer of drugs based on dihydro folate reductase (DHFR) inhibitors. The company develops DHFR-inhibiting therapeutics with applications in the treatment of inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease.

SoftCure Headquarter Location

Fogdevreten 2

Solna, 171 65,


46 70 302 95 88

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.